← Eichor
Study identifier: NCT06571487 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Growth Hormone Resistance of Beta-cells A

Condition: Gestational Diabetes · Obesity · Healthy  ·  Sponsor: University of Missouri-Columbia

PhaseN/A
Planned participants30
Who can joinFemale, 18 Years to 45 Years
Healthy volunteersYes

About this study

The purpose of the research study is to better understand how beta-cells (cells in the pancreas that make insulin and help regulate blood sugar) respond to growth hormone in people with a personal history of gestational diabetes (high blood sugar in pregnancy) at the University of Missouri. The aim of the study is to advance understanding of how growth hormone affects beta-cells and risk factors for developing gestational diabetes.

This description comes directly from the study's public registry record.

Talk to the study team

Amanda Heider  ·  573-884-6852  ·  ahmc4@health.missouri.edu

Vasavi Shabrish, PhD  ·  v.shabrish@missouri.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Missouri School of MedicineColumbia, Missouri, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06571487